According to FutureWise analysis, the cancer diagnostics market in 2025 is estimated to be US$113.62 billion and is expected to reach over US$204.89 billion by 2033, growing at a CAGR of 7.65%. The cancer diagnostics market is experiencing significant growth, driven by an increase in cancer prevalence, advancements in early detection technologies, and a greater adoption of personalized medicine. Additionally, rising investments in research and development, along with the expansion of diagnostic laboratories worldwide, are contributing to the growth of this market. The increasing demand for non-invasive and cost-effective diagnostic solutions is also expected to sustain the market's momentum for cancer diagnostics in the coming years. The increasing global cancer burden, along with a rising demand for early and accurate diagnostic tools, fuels this growth. Furthermore, ongoing advancements in genomic and liquid biopsy technologies contribute to this trend. The greater adoption of AI-based imaging and molecular diagnostics is also accelerating market expansion.
Liquid Biopsy & Multi-Cancer Early Detection (MCED)
Liquid biopsies can now detect tumor-derived genetic material (ctDNA) from blood samples, enabling non-invasive cancer detection, monitoring of minimal residual disease, and tracking therapy responses.
Guardant Health's Shield multi-cancer detection blood test recently received an FDA "Breakthrough Device" designation. It detects eight types of cancer using methylation signatures, achieving approximately 98.6% specificity and 75% sensitivity.
Cancer is a group of diseases defined by the spread of abnormal cells and uncontrolled growth in the body. Early detection of cancer is critical for successful treatment and management of the disease. The goal of cancer diagnostics is to detect cancer early, determine its stage and type, and guide treatment decisions. The process of determining the existence and characteristics of cancerous cells is known as cancer diagnostics. Imaging tests, biopsies, blood tests, and other laboratory studies are a few methods and steps used to detect and examine cancer cells. Cancer diagnostics aim to pinpoint the type, location, stage, and severity of the disease, in addition to determining the best course of action. Successful cancer therapy and disease management depend on early detection and an accurate diagnosis.
Imaging tests, such as, CT scans, X-rays, PET, and MRI scans, are commonly used in cancer diagnostics to create images of the internal structures of the body. These tests can detect tumors and assess the extent of the disease, as well as monitor the effectiveness of treatment. Laboratory tests are also important in cancer diagnostics and are used to detect substances or markers in the blood or other bodily fluids that may be associated with cancer. Common laboratory tests used in cancer diagnosis include complete blood count, tumor markers, and biopsies. Biopsies are a crucial component of cancer diagnostics, involving the removal of a small tissue sample from a suspicious area in the body for examination under a microscope. Different types of biopsies may be used, including core needle biopsy, surgical biopsy and fine-needle aspiration biopsy. Biopsies can help to confirm the diagnosis of cancer and determine its type.
FutureWise Market Research has released a report that provides an intricate analysis of Cancer Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cancer Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry, and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.